My guest is Dr. Marc Swogger from the University of Rochester Medical Center, Department of Psychiatry. Dr. Swogger is a social scientist and psychologist who studies substance use. He has co-authored multiple studies on the individual and public health effects of the use of kratom. 

Studies discussed in this interview:

Marc T. Swogger, Elaine Hart, Fire Erowid, Earth Erowid, Nicole Trabold, Kaila Yee, Kimberly A. Parkhurst, Brittany M. Priddy & Zach Walsh (2015) Experiences of Kratom Users: A Qualitative Analysis, Journal of Psychoactive Drugs, 47:5, 360-367, DOI: 10.1080/02791072.2015.1096434

Coe MA, Pillitteri JL, Sembower MA, Gerlach KK, Henningfield JE. Kratom as a substitute for opioids: Results from an online survey. Drug Alcohol Depend. 2019;202:24‐32. doi: 10.1016/j.drugalcdep.2019.05.005 https://pubmed.ncbi.nlm.nih.gov/31284119/

Swogger MT, Walsh Z. Kratom use and mental health: A systematic review. Drug Alcohol Depend. 2018;183:134‐140. doi:10.1016/j.drugalcdep.2017.10.012 https://pubmed.ncbi.nlm.nih.gov/29248691/

Prozialeck WC, Avery BA, Boyer EW, et al. Kratom policy: The challenge of balancing therapeutic potential with public safety. Int J Drug Policy. 2019;70:70‐77. doi:10.1016/j.drugpo.2019.05.003 https://www.sciencedirect.com/science/article/pii/S0955395919301252?via%3Dihu

Grundmann O, Brown PN, Henningfield J, Swogger M, Walsh Z. The therapeutic potential of kratom. Addiction. 2018;113(10):1951‐1953. doi:10.1111/add.14371 https://onlinelibrary.wiley.com/doi/epdf/10.1111/add.1437

Singh D, Narayanan S, Suraya S, et al. Public Perceptions toward Kratom (Mitragyna Speciosa) Use in Malaysia [published online ahead of print, 2020 Mar 10]. J Psychoactive Drugs. 2020;1‐7. doi:10.1080/02791072.2020.1738603 https://pubmed.ncbi.nlm.nih.gov/32153252/

Saref A, Suraya S, Singh D, et al. Self-Report Data on Regular Consumption of Illicit Drugs and HIV Risk Behaviors after Kratom (Mitragyna Speciosa korth.) Initiation among Illicit Drug Users in Malaysia [published online ahead of print, 2019 Nov 4]. J Psychoactive Drugs. 2019;1‐7. doi:10.1080/02791072.2019.1686553 https://www.ncbi.nlm.nih.gov/pubmed/31682782

Singh D, Müller CP, Vicknasingam BK, Mansor SM. Social Functioning of Kratom (Mitragyna speciosa) Users in Malaysia. J Psychoactive Drugs. 2015;47(2):125‐131. doi:10.1080/02791072.2015.1012610 https://pubmed.ncbi.nlm.nih.gov/25950592/

Eggleston W, Stoppacher R, Suen K, Marraffa JM, Nelson LS. Kratom Use and Toxicities in the United States. Pharmacotherapy. 2019;39(7):775‐777. doi:10.1002/phar.2280 https://pubmed.ncbi.nlm.nih.gov/31099038/

Grundmann O, Brown PN, Boyer EW, et al. Critique of “Kratom Use and Toxicities in the United States”. Pharmacotherapy. 2019;39(11):1119‐1120. doi:10.1002/phar.2336 https://accpjournals.onlinelibrary.wiley.com/doi/full/10.1002/phar.2336

Kratom Science blog post on Jack Henningfield’s initial statement about “Kratom Use and Toxicities in the United States” https://www.kratomscience.com/2019/07/17/widely-publicized-report-on-poison-control-calls-about-kratom-is-flawed-says-kratom-expert/

Music: Risey, "Memories of Thailand"

Written and produced by Brian Gallagher for KratomScience.com

Disclaimer: There is no content on the Kratom Science Podcast nor on KratomScience.com that in any way constitutes medical claims or medical advice. You should consult a medical professional for medical advice and we believe this sincerely. Take care.

###